NAT HEART & LUNG INST has a total of 16 patent applications. Its first patent ever was published in 1991. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are STICHTING HET NEDERLANDS KANKER INST ANTONI VAN LEEUWENHOEK ZIEKENHUIS, CEDARS-SINAI MEDICAL CENTER and Université Libre de Bruxelles.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 3 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology | |
#4 | Medical technology | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Analysing materials | |
#3 | Peptides | |
#4 | Diagnosis and surgery | |
#5 | Unspecified technologies | |
#6 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Cole Peter John | 4 |
#2 | Redington Andrew | 3 |
#3 | Hsuan John Justin | 2 |
#4 | Williams Timothy John | 2 |
#5 | Jose Peter John | 2 |
#6 | Barnes Neil Christopher | 2 |
#7 | Griffiths-Johnson David A | 2 |
#8 | Wills Peter John | 2 |
#9 | Kay Anthony Barry | 2 |
#10 | Redington Andrew Mortlake Road | 1 |
Publication | Filing date | Title |
---|---|---|
GB9408602D0 | Chemotactic cytokine | |
GB9408053D0 | Pharmaceutical preparation | |
GB9318984D0 | Chemotactic cytokine | |
GB9306640D0 | Diagnosis of rejection of transplanted organs | |
GB9216656D0 | Implantable occluder devices for medical use | |
GB9213364D0 | Detection method | |
AU8910891A | Treatment of lung diseases |